Humana Inc. (NYSE: HUM), a leading health and well-being company, on Tuesday reported a wider net loss for the fourth quarter of 2024 despite an increase in revenues.
- Revenues increased about 10% to $29.2 billion in the December quarter from $26.5 billion a year earlier
- The company reported a loss of $2.16 per share for the fourth quarter, on an adjusted basis, compared to a loss of $0.11 per share a year earlier
- Including special items, Q4 net loss widened to $693 million or $5.76 per share from $541 million or $4.42 per share in Q4 2023
- The Insurance segment adjusted benefit ratio was 91.9% in Q4, including a 20-basis point increase related to incremental Star Ratings investments
- For fiscal 2025, the management expects earnings, on a reported basis, to be $15.88 per share
- Adjusted earnings are expected to be $16.25 per share in fiscal 2025
- The company expects individual Medicare Advantage annual memberships to decline by about 550,000 or approximately 10% in FY25, compared to 2024
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Important takeaways from Conagra Brands’ Q3 2025 report
Conagra Brands, Inc. (NYSE: CAG) has reported weaker-than-expected revenue and profit for the February quarter, with sales declining across all business segments amid softer demand and persistent supply challenges. The
Main takeaways from Lamb Weston’s (LW) Q3 2025 earnings report
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) jumped 9% on Thursday after the company delivered better-than-expected results for the third quarter of 2025 and reaffirmed its outlook for the
Summary: Tesla (TSLA) reports Q1 2025 production, deliveries
Tesla Inc. (NASDAQ: TSLA) has announced results of vehicle production and deliveries for the first quarter of 2025. The company also provided data on the deployment of energy storage products
